Skip to Content

49 Results Found

  • Article
  • Open Access
3 Citations
2,694 Views
12 Pages

Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas

  • Shih-Jen Chang,
  • Huiyuan Wang,
  • Jialin Chen,
  • Qianyi Chen,
  • Lei Chang,
  • Yongzhuo Huang,
  • Yajing Qiu and
  • Xiaoxi Lin

Infantile hemangiomas (IH) leave sequelae after involution. Topical application of timolol maleate (TM) is the mainstream treatment for superficial lesions but is limited by its low penetrable properties. We aimed to develop a superior skin permeatio...

  • Article
  • Open Access
10 Citations
4,038 Views
14 Pages

A comparative study between two stability-indicating chromatographic methods for the assay of brinzolamide and timolol maleate in the co-existence of the probable carcinogenic oxidative degradation product of timolol maleate in their ophthalmic formu...

  • Case Report
  • Open Access
4,235 Views
4 Pages

Betaxolol Ophthalmic Solution as Alternative Treatment for Patients with Timolol Allergy: A Case Report

  • Olivia Müllertz,
  • Jette Jacobsen,
  • Jacob P. Thyssen,
  • Anna Horwitz and
  • Miriam Kolko

30 July 2020

Background: To establish if an allergy towards all β-blockers, as a group, should be assumed, if an allergic reaction is observed while using one specific β-blocking agent. Case presentation: The non-selective β-blocker timolol caused...

  • Article
  • Open Access
9 Citations
3,215 Views
11 Pages

TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)—A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial

  • Kornelia E. C. Andorfer,
  • Florian Zeman,
  • Michael Koller,
  • Judith Zeller,
  • René Fischer,
  • Caroline T. Seebauer,
  • Veronika Vielsmeier,
  • Christopher Bohr and
  • Thomas S. Kühnel

To date, there is no approved local therapeutic agent for the treatment of epistaxis due to hereditary hemorrhagic telangiectasia (HHT). Several case reports suggest the topical use of timolol. This monocentric, prospective, randomized, placebo-contr...

  • Article
  • Open Access
2 Citations
3,168 Views
17 Pages

30 January 2023

The study reveals the development of novel hydrogels based on sulfobetaine methacrylate (SB) and vinyl pyrrolidone (VP) copolymers as potential contact lenses delivery systems of timolol maleate (TM). The novel copolymer networks demonstrated composi...

  • Article
  • Open Access
15 Citations
3,680 Views
13 Pages

A sustainable reversed-phase chromatographic method has been developed and validated for the simultaneous determination of three active pharmaceutical ingredients, dorzolamide, brinzolamide, and timolol, used to treat glaucoma. The eco-friendly solve...

  • Article
  • Open Access
3 Citations
2,784 Views
19 Pages

The Study on Timolol and Its Potential Phototoxicity Using Chemical, In Silico and In Vitro Methods

  • Karolina Lejwoda,
  • Anna Gumieniczek,
  • Agata Filip and
  • Beata Naumczuk

11 January 2024

Timolol (TIM) is a non-selective ß-adrenergic receptor antagonist used orally for the treatment of hypertension and heart attacks, and topically for treating glaucoma; lately, it has also been used in some specific dermatological problems. In t...

  • Article
  • Open Access
141 Citations
5,245 Views
18 Pages

5 October 2010

The poor bioavailability and therapeutic response exhibited by conventional ophthalmic preparations due to rapid precorneal elimination, dilution and nasolacrimal drainage of the drug may be vanquished by the use of in situ gelling systems that are...

  • Article
  • Open Access
8 Citations
4,222 Views
12 Pages

7 February 2022

To compare the efficacy, patient-reported satisfaction, and safety of preservative-free (PF)-tafluprost, PF-dorzolamide/timolol and preservative-containing (P)-latanoprost in Korean glaucoma patients with ocular surface disease (OSD). In a multicente...

  • Article
  • Open Access
1,034 Views
26 Pages

19 September 2025

It was previously demonstrated that timolol (TIM), naphazoline (NAPH), and diflunisal (DIF) are susceptible to degradation when exposed to extreme pH conditions and UV/Vis light. However, their stability in the presence of pharmaceutical excipients r...

  • Article
  • Open Access
4 Citations
4,601 Views
12 Pages

Magnesium Hydroxide Nanoparticles Improve the Ocular Hypotensive Effect of Twice Daily Topical Timolol Maleate in Healthy Dogs

  • Mizuki Kita,
  • Kazutaka Kanai,
  • Hiroki Mitsuhashi,
  • Tomoki Noguchi,
  • Noriaki Nagai,
  • Mizuki Yamaguchi,
  • Yuya Otaka,
  • Rina Kudo,
  • Yohei Yamashita and
  • Kazuki Tajima

23 August 2021

Timolol maleate (TM), a beta-adrenergic receptor antagonist, is widely used for canine antiglaucoma eye drops; however, its bioavailability is <5%. Our previous study revealed that magnesium hydroxide nanoparticles (nMH) have potency in improving...

  • Article
  • Open Access
26 Citations
5,010 Views
13 Pages

Ocular Co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation

  • Elissavet Taka,
  • Christina Karavasili,
  • Nikolaos Bouropoulos,
  • Thomas Moschakis,
  • Dimitrios D. Andreadis,
  • Constantinos K. Zacharis and
  • Dimitrios G. Fatouros

Effective pharmacotherapy during glaucoma treatment depends on interventions that reduce intraocular pressure (IOP) and retain the IOP lowering effect for sufficient time so as to reduce dosing frequency and enhance patient adherence. Combination ant...

  • Article
  • Open Access
506 Views
14 Pages

Real-World Transition to a Preservative-Free Fixed Combination of Dorzolamide/Timolol: Impact on the Ocular Surface Microenvironment, Safety, Tolerability, and Efficacy

  • Ana Sanseau,
  • Arturo Burchakchi,
  • Fernando Cataldi,
  • Héctor Fontana,
  • Alejo Peyret,
  • Giselle Rodríguez,
  • Ailín Fantacone,
  • María Silvia Passerini and
  • Javier F. Casiraghi

16 January 2026

Background and Objectives: This study evaluates the safety, tolerability, and efficacy of preservative-free Dorzolamide 2%-Timolol 0.5% (PF-DT), with a focus on improving the ocular microenvironment in a real-world transition setting. Materials and M...

  • Article
  • Open Access
13 Citations
3,962 Views
28 Pages

Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels

  • Carmen M. Arroyo-García,
  • Daniela Quinteros,
  • Santiago D. Palma,
  • Cesáreo J. Jiménez de los Santos,
  • José R. Moyano,
  • Antonio M. Rabasco and
  • María Luisa González-Rodríguez

The purpose of this study was to design, for the first time, a co-loaded liposomal formulation (CLL) for treatment of glaucoma including timolol maleate (TM) in the lipid bilayer and acetazolamide (Acz)-(2-hydroxy)propyl β-cyclodextrin (HPβ...

  • Article
  • Open Access
2 Citations
4,464 Views
18 Pages

26 February 2025

The objectives of the study were to compare the efficacy and safety using ocular surface assessment between preserved and preservative-free brimonidine/timolol fixed-combination eye drops in glaucoma or ocular hypertension patients. Methods: This stu...

  • Article
  • Open Access
1 Citations
1,456 Views
5 Pages

The Effect of Nebulized Dorzolamide/Timolol Fixed Combination Mist versus Drops on Retrobulbar Blood Flow and Intraocular Pressure in Glaucoma Patients

  • Ingrida Janulevičienė,
  • Lina Šiaudvytytė,
  • Rūta Baršauskaitė,
  • Vaida Dilienė,
  • Loreta Kuzmienė,
  • Brent Siesky and
  • Alon Harris

4 August 2013

Objective. The aim of this study was to evaluate intraocular pressure (IOP), retrobulbar blood flow (RBF), and ocular side effects after the application of topical dorzolamide/timolol fixed combination (DTFC) drops vs topical nebulized DTFC mist in p...

  • Article
  • Open Access
5 Citations
2,420 Views
20 Pages

Background/objectives: The aim of the study was to create a nanofiber insert incorporating Timolol (TIM) and Dorzolamide (DOR), targeting the management of glaucoma. This condition encompasses a variety of chronic, advancing ocular disorders typicall...

  • Article
  • Open Access
5 Citations
8,211 Views
14 Pages

21 March 2012

Objective: To compare the effects of dorzolamide and timolol add-on therapy in open-angle glaucoma (OAG) patients previously treated with prostaglandin analogue (Pg), by evaluating fluctuations in the intraocular (IOP), blood (BP), ocular perfusion p...

  • Article
  • Open Access
40 Citations
6,690 Views
13 Pages

The Effect of Polymers on Drug Release Kinetics in Nanoemulsion In Situ Gel Formulation

  • K. Reeta Vijaya Rani,
  • Sruthi Rajan,
  • Mullaicharam Bhupathyraaj,
  • R. Krishna Priya,
  • Nirmala Halligudi,
  • Mohammad Abobakr Al-Ghazali,
  • Sathvik B. Sridhar,
  • Javedh Shareef,
  • Sabin Thomas and
  • Pandurang D. Pol
  • + 1 author

21 January 2022

Glaucoma is an ocular condition characterized by elevated intraocular pressure (IOP). Conventional treatments of glaucoma face poor corneal permeability and bioavailability. To address these issues, a nanoemulsion in situ gel of Timolol maleate was d...

  • Article
  • Open Access
3 Citations
2,283 Views
9 Pages

26 April 2023

Purpose: To investigate the effect of fixed combination versus concomitant unfixed topical glaucoma treatment on patients’ adherence and ocular surface health. Patients and Methods: This is a 6-month, prospective, parallel-group, observational...

  • Article
  • Open Access
14 Citations
4,194 Views
13 Pages

22 August 2022

Meibomian gland dysfunction is one of the main causes of dry eye disease and has limited therapeutic options. In this study, we investigated the biological function of the beta 2-adrenergic receptor (ADRB2)/protein kinase A (PKA) pathway in lipid syn...

  • Article
  • Open Access
30 Citations
3,764 Views
26 Pages

A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma

  • Massimo Dal Monte,
  • Maurizio Cammalleri,
  • Rosario Amato,
  • Salvatore Pezzino,
  • Roberta Corsaro,
  • Paola Bagnoli and
  • Dario Rusciano

4 December 2020

Melatonin is of great importance for regulating several eye processes, including pressure homeostasis. Melatonin in combination with agomelatine has been recently reported to reduce intraocular pressure (IOP) with higher efficacy than each compound a...

  • Article
  • Open Access
41 Citations
5,337 Views
18 Pages

Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents

  • Sergio Esteban-Pérez,
  • Vanessa Andrés-Guerrero,
  • José Javier López-Cano,
  • Irene Molina-Martínez,
  • Rocio Herrero-Vanrell and
  • Irene Bravo-Osuna

The increment in ocular drug bioavailability after topical administration is one of the main challenges in pharmaceutical technology. For several years, different strategies based on nanotechnology, hydrogels or implants have been evaluated. Nowadays...

  • Case Report
  • Open Access
7 Citations
5,605 Views
10 Pages

Safe and Effective Treatment of Intracranial Infantile Hemangiomas with Beta-Blockers

  • Aoife Naughton,
  • Ariel Yuhan Ong and
  • Goran Darius Hildebrand

Infantile hemangiomas are common benign vascular tumors but are rarely found in an intracranial location. Our literature review identified 41 reported cases. There is no general consensus on management of these rare lesions and until recently, treatm...

  • Article
  • Open Access
1,572 Views
11 Pages

Infantile Haemangioma in the Romanian Paediatric Population—Characteristics and Therapeutic Approaches

  • Anca-Maria Raicu,
  • George-Florin Danila,
  • Ionut Fernando Secheli,
  • Eugenia Claudia Bratu and
  • Dana Galieta Minca

30 July 2023

Infantile haemangioma (IH) is the most common benign tumour in childhood, with an incidence of 4% to 12%. Aim: to describe the characteristics of infantile haemangioma in a sample of Romanian children <2 years old at diagnosis, types of treatment...

  • Review
  • Open Access
12 Citations
14,046 Views
23 Pages

The Evaluation, Diagnosis, and Management of Infantile Hemangiomas—A Comprehensive Review

  • Arnes Rešić,
  • Zoran Barčot,
  • Dubravko Habek,
  • Zenon Pogorelić and
  • Marko Bašković

10 January 2025

Infantile hemangioma (IH) is the most common pediatric benign vascular tumor. Its pathogenesis is still poorly understood, and it usually appears during the first few weeks of life and follows a characteristic natural course of proliferation and invo...

  • Article
  • Open Access
9 Citations
2,374 Views
10 Pages

8 January 2022

Drug-diffusion kinetics in 2-hydroxyethyl methacrylate hydrogels were studied as a function of the crosslinking density and porosity. By varying the concentration of the crosslinker, tetraethylene glycol dimethacrylate, we demonstrated how the releas...

  • Article
  • Open Access
3 Citations
2,439 Views
9 Pages

Topical Treatment of Elevated Intraocular Pressure in Patients with Graves’ Orbitopathy

  • Magdalena Gumińska,
  • Roman Goś,
  • Janusz Śmigielski and
  • Michał S. Nowak

Purpose: In this study, we evaluated the efficacy of topical hypotensive treatment and/or systemic corticosteroids therapy in patients with elevated intraocular pressure and Graves’ orbitopathy (GO). Methods: We included 172 eyes in 86 individu...

  • Review
  • Open Access
10 Citations
3,847 Views
10 Pages

26 July 2022

Latanoprostene bunod (LBN) 0.024%, a newly approved glaucoma eye drop, is metabolized into latanoprost acid and a nitric oxide (NO)-donating moiety, thus increasing the outflow of aqueous humor through the uveoscleral and trabecular routes, respectiv...

  • Review
  • Open Access
1 Citations
4,207 Views
21 Pages

Structural and Pharmacological Insights into Propranolol: An Integrated Crystallographic Perspective

  • Adrianna Witczyńska,
  • Łukasz Fijałkowski,
  • Dagmara Mirowska-Guzel,
  • Kamila Blecharz-Klin and
  • Alicja Nowaczyk

16 October 2025

Propranolol is a non-selective β-adrenergic receptor antagonist widely used in cardiovascular and neurological therapy. Its naphthalene-based structure contributes to its high lipophilicityand central nervous system penetration. Clinically, prop...

  • Article
  • Open Access
10 Citations
2,845 Views
13 Pages

Microwave-Assisted Synthesis of 3-Hydroxy-2-oxindoles and Pilot Evaluation of Their Antiglaucomic Activity

  • Alexander M. Efremov,
  • Olga V. Beznos,
  • Roman O. Eremeev,
  • Natalia B. Chesnokova,
  • Elena R. Milaeva,
  • Elena F. Shevtsova and
  • Natalia A. Lozinskaya

Glaucoma is a widespread neurodegenerative disease for which increased intraocular pressure (IOP) is a primary modifiable risk factor. Recently, we have observed that compounds with oxindole scaffolds are involved in the regulation of intraocular pre...

  • Review
  • Open Access
17 Citations
4,957 Views
23 Pages

Progress in the Enantioseparation of β-Blockers by Chromatographic Methods

  • Yiwen Yang,
  • Yehui Wang,
  • Zongbi Bao,
  • Qiwei Yang,
  • Zhiguo Zhang and
  • Qilong Ren

17 January 2021

β-adrenergic antagonists (β-blockers) with at least one chiral center are an exceedingly important class of drugs used mostly to treat cardiovascular diseases. At least 70 β-blockers have been investigated in history. However, only a f...

  • Article
  • Open Access
9 Citations
5,360 Views
14 Pages

This paper reports the in vitro characterization of the interaction between the phosphate groups of DNA and the protonated species of drugs with basic groups through the determination of the affinity constants, the reversibility of the interaction, a...

  • Article
  • Open Access
28 Citations
6,865 Views
15 Pages

Role of Histamine H3 Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma

  • Cecilia Lanzi,
  • Laura Lucarini,
  • Mariaconcetta Durante,
  • Silvia Sgambellone,
  • Alessandro Pini,
  • Stefano Catarinicchia,
  • Dorota Łażewska,
  • Katarzyna Kieć-Kononowicz,
  • Holger Stark and
  • Emanuela Masini

24 February 2019

Intraocular pressure (IOP) has a tendency to fluctuate throughout the day, reaching its peak in the early morning in healthy subjects or glaucoma patients. Likewise, histamine tone also fluctuates over time, being lower at nighttime. Numerous studies...

  • Case Report
  • Open Access
1 Citations
4,193 Views
6 Pages

19 January 2023

Kaposi sarcoma is relatively common after solid organ transplantation, but very rare after hematopoietic stem cell transplant (HSCT). Here we are reporting a rare case of Kaposi sarcoma in a child after HSCT. An 11-year-old boy with Fanconi anemia wa...

  • Article
  • Open Access
2 Citations
2,589 Views
15 Pages

(1) Background: A rise in intraocular pressure (IOP) and decreased retinal ganglion cells are frequent indicators of effective modeling of chronic ocular hypertension in mice. In this study, the sensitivity of the mouse model to pharmaceutical therap...

  • Article
  • Open Access
22 Citations
4,822 Views
10 Pages

17 March 2022

Beta adrenoblockers are a large class of drugs used to treat cardiovascular diseases, migraines, glaucoma and hyperthyroidism. Over the last couple of decades, the anticancer effects of these compounds have been extensively studied. However, the exac...

  • Article
  • Open Access
21 Citations
4,327 Views
11 Pages

Dry Eye Symptoms and Ocular Pain in Veterans with Glaucoma

  • Aubrey R Tirpack,
  • Elizabeth Vanner,
  • James M Parrish,
  • Anat Galor,
  • Hong-Uyen Hua and
  • Sarah R Wellik

22 July 2019

Dry eye and glaucoma are two frequently encountered ocular conditions, which can lead to substantial morbidity and decreased quality of life. Patients on topical glaucoma medications are known to be at greater risk for ocular surface symptoms. Vetera...

  • Article
  • Open Access
3 Citations
2,318 Views
10 Pages

Underreporting and Triggering Factors for Reporting ADRs of Two Ophthalmic Drugs: A Comparison between Spontaneous Reports and Active Pharmacovigilance Databases

  • Homero Contreras-Salinas,
  • Leopoldo Martín Baiza-Durán,
  • Manuel Alejandro Bautista-Castro,
  • Diego Rodrigo Alonso-Rodríguez and
  • Lourdes Yolotzin Rodríguez-Herrera

31 October 2022

(1) Aims of the study: calculating the underreporting ratio for two different medications, a fixed combination of 0.5% timolol + 0.2% brimonidine + 2.0% dorzolamide (antiglaucoma) and a fixed combination of sodium hyaluronate 0.1% + chondroitin sulfa...

  • Article
  • Open Access
2,124 Views
14 Pages

Plant Iridoids Affect Intraocular Pressure and Vascular Flow in the Rabbit Eye

  • Dorota Szumny,
  • Tomasz Sozański,
  • Adam Szeląg and
  • Antoni Szumny

1 May 2025

For plant-derived raw materials, there are very few studies regarding the effect of intraocular administration on intraocular pressure (IOP) and associated blood flow. Traditional folk medicine uses many natural resources for eye disorders. However,...

  • Case Report
  • Open Access
2,689 Views
8 Pages

Spontaneous Ectopia Lentis in Retinitis Pigmentosa: A Case Report and Review of the Literature

  • Cristina Nicolosi,
  • Giulio Vicini,
  • Lorenzo Beni,
  • Noemi Lombardi,
  • Marco Branchetti,
  • Dario Giattini,
  • Vittoria Murro,
  • Daniela Bacherini,
  • Andrea Sodi and
  • Fabrizio Giansanti

8 August 2024

Purpose: We report the successful surgical treatment of a case of spontaneous complete anterior crystalline lens luxation in a patient affected by retinitis pigmentosa (RP), associated with elevated intraocular pressure and pupillary block. Additiona...

  • Article
  • Open Access
35 Citations
5,473 Views
13 Pages

Microscale Thermophoresis as a Screening Tool to Predict Melanin Binding of Drugs

  • Laura Hellinen,
  • Sina Bahrpeyma,
  • Anna-Kaisa Rimpelä,
  • Marja Hagström,
  • Mika Reinisalo and
  • Arto Urtti

Interactions between drugs and melanin pigment may have major impacts on pharmacokinetics. Therefore, melanin binding can modify the efficacy and toxicity of medications in ophthalmic and other disease of pigmented tissues, such as melanoma. As melan...

  • Article
  • Open Access
4 Citations
3,680 Views
17 Pages

We tested five chemically and metabolically stable prostaglandin (PG) receptor agonists in a mouse model of dexamethasone-induced ocular hypertension (OHT). Whilst all compounds significantly (p < 0.05, ANOVA) lowered intraocular pressure (IOP) af...

  • Article
  • Open Access
12 Citations
5,823 Views

RETRACTED: Retinal Pigment Epithelial Cell Line with Fast Differentiation and Improved Barrier Properties

  • Laura Hellinen,
  • Lea Pirskanen,
  • Unni Tengvall-Unadike,
  • Arto Urtti and
  • Mika Reinisalo

Retinal pigment epithelium (RPE) acts as an outer blood–retinal barrier that limits the access of circulating xenobiotics to the eye. In addition, the RPE limits posterior elimination of intravitreally injected drugs to circulation. Thus, permeation...

  • Article
  • Open Access
7 Citations
4,586 Views
12 Pages

β-blockers Reverse Agonist-Induced β2-AR Downregulation Regardless of Their Signaling Profile

  • Sonia Maccari,
  • Vanessa Vezzi,
  • Federica Barbagallo,
  • Tonino Stati,
  • Barbara Ascione,
  • Maria Cristina Grò,
  • Liviana Catalano,
  • Giuseppe Marano,
  • Paola Matarrese and
  • Paola Molinari
  • + 1 author

Altered β-adrenergic receptor (β-AR) density has been reported in cells, animals, and humans receiving β-blocker treatment. In some cases, β-AR density is upregulated, but in others, it is unaffected or even reduced. Collectively,...

  • Article
  • Open Access
3 Citations
3,266 Views
12 Pages

The Characteristics of Care Provided to Population(s) in Precarious Situations in 2015. A Preliminary Study on the Universal Health Cover in France

  • François Birault,
  • Stéphanie Mignot,
  • Nicole Caunes,
  • Philippe Boutin,
  • Emilie Bouquet,
  • Marie-Christine Pérault-Pochat and
  • Bérangère Thirioux

Background: The French Universal Health Cover (CMU) aims to compensate for inequalities between precarious and non-precarious populations, enabling the former to access to free healthcare. These measures rely on the principle that precarious populati...

  • Systematic Review
  • Open Access
1,574 Views
14 Pages

Central Contrast Sensitivity as an Outcome Measure in Randomized Controlled Trials in Glaucoma—A Systematic Review

  • Alexander Sverstad,
  • Jens Riis Møller,
  • Gianni Virgili,
  • Augusto Azuara-Blanco,
  • Josefine Freiberg,
  • Simone Ahrensberg,
  • Olav Kristianslund,
  • Goran Petrovski and
  • Miriam Kolko

30 June 2025

Purpose: Standard automated perimetry (SAP) remains the gold standard functional test in glaucoma, used primarily for evaluating peripheral vision loss. Central contrast sensitivity (CCS) has emerged as a potential early functional marker of glaucoma...

  • Article
  • Open Access
1 Citations
862 Views
23 Pages

Nimodipine Nanoparticles: A Promising Approach for Glaucoma Management

  • Doaa N. Maria,
  • Sara N. Maria,
  • Monica M. Jablonski and
  • Mohamed Moustafa Ibrahim

Background/Objectives: Glaucoma is a multifactorial eye disease that can cause optic nerve damage and irreversible blindness. It is considered a significant public health problem worldwide. Topical intraocular pressure (IOP)-lowering eye preparations...

  • Case Report
  • Open Access
6 Citations
7,756 Views
6 Pages

Foster Kennedy Syndrome (FKS): A Case Report

  • Mutali Musa,
  • Gladness Aluyi-Osa and
  • Marco Zeppieri

12 July 2022

(1) Background: Foster Kennedy syndrome (FKS) is an ophthalmological condition characterized by an insidious reduction in vision in one eye, accompanied by clinically significant papilledema in the fellow eye. The unilateral loss of vision and optic...